Reaction Details Report a problem with these data
Target
Arginase-1
Ligand
BDBM642254
Substrate
n/a
Meas. Tech.
Inhibition of Arginase
IC50
<101±n/a nM
Citation
 Kurhade, S; Dömling, A Arginase inhibitors US Patent  US11845767 Publication Date 12/19/2023 
Target
Name:
Arginase-1
Synonyms:
ARG1 | ARGI1_HUMAN | Liver-type arginase | Type I arginase
Type:
PROTEIN
Mol. Mass.:
34737.53
Organism:
Homo sapiens (Human)
Description:
ChEMBL_978893
Residue:
322
Sequence:
MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK
  
Inhibitor
Name:
BDBM642254
Synonyms:
(5-amino-5-(1-(4-cyanobenzyl)-1H- tetrazol-5-yl)pentyl)boronic acid | US11845767, Example 299
Type:
Small organic molecule
Emp. Form.:
C14H19BN6O2
Mol. Mass.:
314.151
SMILES:
NC(CCCCB(O)O)c1nnnn1Cc1ccc(cc1)C#N
Structure:
Search PDB for entries with ligand similarity: